We recently compiled a list of the Top 12 Stocks to Buy According to Bourgeon Capital. In this article, we are going to take ...
Sound Shore Management, an investment management firm, has released its investor letter for the fourth quarter of 2024. A ...
Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries, and Medincell announced that the supplemental New Drug ...
In a report released today, David Amsellem from Piper Sandler reiterated a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a ...
UZEDY is currently approved for use every one or two months as a subcutaneous long-acting injectable (LAI) for the treatment ...
And good morning, good afternoon, and good evening. And thank you all for taking the time to talk about this important program for Teva, our Duvakitug program. If I can have the next slide.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI for all indications matching the reference ...
Sanctuary Advisors LLC boosted its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 132.4% in the 4th quarter, Holdings Channel reports.The fund owned 81,643 ...
Teva Pharmaceutical Industries and partner Alvotech said the Food and Drug Administration agreed to review their AVTO6 ...
New research by Teva Pharmaceuticals Europe shows that 46% of generic medicines from the EU Critical List of Medicines are supplied by only one provider. This ...
U.S. President Donald Trump's administration needs to speed up generic drug approvals and exempt some drugs from funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results